Free shipping on all orders over $ 500

MW-150

Cat. No. M28723

All AbMole products are for research use only, cannot be used for human consumption.

MW-150 Structure
Synonym:

MW01-18-150SRM

Price and Availability

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

MW150 (MW01-18-150SRM) is a selective, CNS penetrant, and orally active inhibitor of p38α MAPK with a Ki of 101 nM. MW-150 inhibits the ability of the endogenous p38α MAPK to phosphorylate an endogenous substrate MK2 in activated glia.

Chemical Information
Molecular Weight 381.47
Formula C24H23N5
CAS Number 1628502-91-9
Form Solid
Solubility (25°C) DMSO 40 mg/mL (ultrasonic)
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] João P Mendes, et al. Biosensors (Basel). Differential Refractometric Biosensor for Reliable Human IgG Detection: Proof of Concept

[2] Fabiana V Campos, et al. Toxins (Basel). Fish Cytolysins in All Their Complexity

[3] Xiaochuan Dai, et al. Nano Lett. Modularized Field-Effect Transistor Biosensors

[4] Miro Kasum, et al. Biochem Med (Zagreb). Macroprolactinemia: new insights in hyperprolactinemia

[5] Daniela Fattori, et al. Drugs R D. Fragment-based approach to drug lead discovery: overview and advances in various techniques

Related p38 MAPK Products
SSK1

SSK1 is a senescence-specific killing compound and is a precursor for β-galactosidase, which can reduce the inflammatory response. SSK1 can activate the phosphorylation of p38 MAPK and MKK3/MKK6 in senescent cells, promote mitochondrial DNA damage and selectively killed senescent cells.

p38 MAP Kinase Inhibitor III

p38 MAP Kinase Inhibitor III is a p38 MAPK inhibitor with an IC50 of 0.9 μM. p38 MAP Kinase Inhibitor III also inhibits IL-1β and TNF-α release with IC50 values of 0.37 μM and 0.044 μM, respectively.

(R)-STU104 

(R)-STU104 is a potent and orally active TAK1-MKK3 interaction inhibitor with IC50s of 0.58 μM and 4.0 μM for TNF-α and MKK3 phosphorylation.

SB 706504 

SB 706504 is a potent p38 MAPK inhibitor that inhibits Lipopolysaccharides-stimulated inflammatory gene expression in macrophages in chronic obstructive pulmonary disease (COPD).

RWJ-67657

RWJ-67657 (JNJ 3026582) is an orally active and selective p38α and p38β MAPK inhibitor with IC50s of 1 and 11 μM, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: MW-150, MW01-18-150SRM supplier, p38 MAPK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.